Tomoyuki Fujii
Papers
1
Total Citations
12
H-Index
1
About
Dr. Tomoyuki Fujii is a pioneering figure in gynecologic oncology, with a focused expertise in the clinical implementation and safety evaluation of robotic-assisted surgeries (RAS) in Japan. His most impactful work, the 2019 study "Early feasibility surveillance of gynecologic robotic‐assisted surgeries in Japan," stands as a cornerstone for the field, amassing 12 citations. This multi-institutional retrospective review of 357 RAS procedures across 24 accredited hospitals provided the first rigorous, large-scale evidence that robotic surgery is both feasible and safe for treating gynecologic malignancies within the Japanese healthcare context. By systematically analyzing perioperative outcomes, Dr. Fujii’s research directly addressed critical gaps in surgical surveillance, establishing benchmarks for safety and efficacy that have guided subsequent clinical adoption and training. His contributions are instrumental in bridging the gap between emerging surgical technologies and evidence-based practice, offering a model for how feasibility studies can inform national surgical policy. Through this landmark work, Dr. Fujii has not only advanced the standard of care for patients with gynecologic cancers but also laid the groundwork for future innovations in minimally invasive oncology.
Research Focus
Key Achievements
Top Papers
- 1